Dainippon Sumitomo

The top 10 advertisers in Big Pharma
Fierce Pharma Marketing
Mon, 05/18/15 - 11:27 am
Pfizer
AbbVie
AstraZeneca
Eli Lilly
JNJ
Actavis
Merck
Bristol-Myers Squibb
Dainippon Sumitomo
Amgen
drug ads
PhIII flop for top Boston cancer stem cell program batters Dainippon Sumitomo
Fierce Biotech
Tue, 05/27/14 - 10:06 am
stem cells
Dainippon Sumitomo
Boston Biomedical
BB1608
colorectal cancer
AstraZeneca takes control of its destiny in Japan with buyout; drugmaker snatches up Sumitomo and gets Forxiga approval there
Fierce Pharma
Wed, 03/26/14 - 01:06 pm
M&A
Japan
Forixga
Dainippon Sumitomo
AstraZeneca
China Biotech In Review: WuXi Makes Deal To Develop Therapeutic Antibody Candidates
Seeking Alpha
Sun, 09/9/12 - 11:16 am
China National Biotech Group
WuXi PharmaTech
China Medical Technologies
Dainippon Sumitomo
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:25 pm
Watson Pharmaceuticals
Theratechnologies
Shire
Savient
Sanofi
Roche
Orphan Europe
Novo Nordisk
Novartis
Merz
JNJ
HRA Pharma
Genzyme
Forest Labs
FDA
Eisai
Dainippon Sumitomo
Chemiche Fabrik Kresussler
Boehringer Ingelheim
Bayer
Auxilium
Amgen
Allergan
Acorda Therapeutics
Two drugs, two price-setting tales
Fierce Pharma
Mon, 12/20/10 - 11:53 am
drug pricing
Celgene
Revlimid
Dainippon Sumitomo
Latuda
Sepracor to become Sunovion Pharmaceuticals
Boston.com
Thu, 07/15/10 - 09:33 am
Sepracor
Sunovion
M&A
Dainippon Sumitomo
FDA Warns Drug Makers On Misleading Promotional Efforts
NASDAQ.com
Fri, 06/18/10 - 08:17 am
FDA
warnings
Cumberland
Auxilium
Dainippon Sumitomo
Eisai
Biotech's Latest Business Mishaps
Seeking Alpha
Mon, 05/10/10 - 09:19 am
Abbott Laboratories
Bristol-Myers Squibb
GSK
InterMune
JNJ
Merck
Pfizer
Newron Pharma
Dainippon Sumitomo
Dainippon Fails to Win U.S. Approval of Epilepsy Drug
Bloomberg
Tue, 05/4/10 - 10:44 am
Dainippon Sumitomo
FDA
epilepsy
Sepracor
Stedesa
Dainippon files for approval of blockbuster schizophrenia drug
Fierce Biotech
Tue, 01/5/10 - 09:10 am
Dainippon Sumitomo
schizophrenia
lurasidone
Sepracor CEO in line for $11M golden handshake
Fierce Biotech
Fri, 10/23/09 - 05:24 am
Sepracor
M&A
Dainippon Sumitomo
Dainippon and Sepracor Deal Emerges
Yahoo/Zacks.com
Thu, 10/15/09 - 10:32 am
Dainippon Sumitomo
Sepracor
M&A
Sepracor shareholders sue to block deal
Fierce Pharma
Wed, 09/9/09 - 10:46 am
Sepracor
M&A
Dainippon Sumitomo
Sepracor's Suitor Is Hard to Understand
Seeking Alpha
Mon, 09/7/09 - 08:40 am
Sepracor
M&A
Dainippon Sumitomo
Is Sepracor the Right Prescription for Dainippon Sumitomo?
WSJ Online
Thu, 09/3/09 - 10:53 am
Sepracor
buyouts
Dainippon Sumitomo
Dainippon Sumitomo Pharma of Japan acquiring US drug maker Sepracor for $2.6 billion
Yahoo/AP
Thu, 09/3/09 - 08:16 am
Dainippon Sumitomo
Sepracor
buyouts